Posts

Survey finds rising optimism that AI will speed drug discovery

on

Astellas takes option on Audax’s preclinical IL-12 cancer drug

on

Lilly says retatrutide beat Ozempic on blood sugar and weight loss

on

GSK expects limited UK job impact from restructuring

on

Biogen’s Apellis deal helps deliver its strongest quarter since 2020

on

Healthcare groups call for risk-based, clearer evidence standards for medical-device GenAI

on

Treasury’s draft could narrow U.S.–China biotech dealmaking

on

J&J touts promising early RIPTAC results in advanced prostate cancer

on

Lilly can continue disputed obesity-drug ads as Novo lawsuit continues

on

AstraZeneca’s gastric ADC: strong survival signal, but second-line reach is uncertain

on

WuXi AppTec raises 2026 outlook after strong nine-month results

on

Artiva ends AlloNK program and cuts 94% of staff

on

Novartis stands by Avidity deal after $1.9 billion del-desiran write-down

on